Gregory Armaos
YOU?
Author Swipe
View article: Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation
Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation Open
View article: Targeting MYC Overexpressing Leukemia with Cardiac Glycoside Proscillaridin Through Downregulation of Histone Acetyltransferases
Targeting MYC Overexpressing Leukemia with Cardiac Glycoside Proscillaridin Through Downregulation of Histone Acetyltransferases Open
Targeting MYC oncogene remains a major therapeutic goal in cancer chemotherapy. Here, we demonstrate that proscillaridin, a cardiac glycoside approved for heart failure treatment exhibit anticancer selectivity towards high MYC expressing l…
View article: Proscillaridin A effects on histone acetylation and C-MYC degradation in acute lymphoblastic leukemia
Proscillaridin A effects on histone acetylation and C-MYC degradation in acute lymphoblastic leukemia Open
La leucémie lymphoblastique aiguë (LLA) représente environ 25% des cancers pédiatriques diagnostiqués chaque année. Dans 80 % des cas, une rémission complète est observée. Cependant, les patients résistants aux traitements ainsi que les pa…